Tenaya Therapeutics Announces RMAT Designation To TN-401
(RTTNews) - Tenaya Therapeutics, Inc. (TNYA) announced the FDA has granted Regenerative Medicine Advanced Therapy designation to TN-401, Tenaya's gene therapy candidate for the treatment of PKP2-associated arrhythmogenic right ventricular cardiomyopathy. Tenaya's RMAT applicatio
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.